Welcome to NGC. Skip directly to: Search Box, Navigation, Content.


Brief Summary

GUIDELINE TITLE

Antibiotic prophylaxis in cardiac surgery.

BIBLIOGRAPHIC SOURCE(S)

  • Society of Thoracic Surgeons Workforce on Evidence Based Surgery. Antibiotic prophylaxis in cardiac surgery. Part 1, duration of prophylaxis. Chicago (IL): Society of Thoracic Surgeons; 2005. 20 p. [56 references]

GUIDELINE STATUS

This is the current release of the guideline.

BRIEF SUMMARY CONTENT

 
RECOMMENDATIONS
 EVIDENCE SUPPORTING THE RECOMMENDATIONS
 IDENTIFYING INFORMATION AND AVAILABILITY
 DISCLAIMER

 Go to the Complete Summary

RECOMMENDATIONS

MAJOR RECOMMENDATIONS

The levels of evidence (A-C) and classification of recommendations (I-III) are defined at the end of the "Major Recommendations" field.

Antimicrobial Resistance

Guideline Panel Conclusion: The duration of a prophylactic antibiotic regimen is directly related to the probability of developing resistant microorganisms.

Optimal Practice: The duration of a prophylactic antibiotic regimen is limited to the shortest amount of time required to effectively minimize the probability of postoperative infection. Class IIa. Level B.

Surgical Site Infection

  1. Chest Tubes and Antibiotic Prophylaxis
    • Guideline Panel Conclusion: The duration of antibiotic prophylaxis should not be dependent on indwelling catheters of any type.
    • Optimal Practice: Decisions regarding the continuation of antibiotic prophylaxis are not guided by the presence of indwelling catheters. Class IIb. Level C.
  2. Single-dose prophylaxis
    • Guideline Panel Conclusion: Single dose antibiotic prophylaxis may be effective in cardiac surgery, but there are inconclusive data to confirm this effectiveness. There is insufficient evidence to recommend use of single-dose prophylaxis in cardiac surgery.
    • Optimal Practice: Single-dose prophylaxis is used in circumstances the surgeon considers optimal for patient care. Class IIa. Level B.
  3. Prophylaxis for 48 hours
    • Guideline Panel Conclusion: Antibiotic prophylaxis of up to 48 hours duration is unlikely to produce antibiotic resistance.
    • Guideline Panel Conclusion: Antibiotic prophylaxis of 48 hours duration is clinically effective in minimizing infectious complications in cardiac surgery.
    • Guideline Panel Conclusion: Antibiotic prophylaxis of 48 hours duration may be as effective as prophylaxis administered for longer than 48 hours.

Summary Conclusions

There is evidence indicating that antibiotic prophylaxis of 48 hours duration is effective. There is some evidence that single-dose prophylaxis or 24-hour prophylaxis may be as effective as 48-hour prophylaxis, but additional studies are necessary before confirming the effectiveness of prophylaxis lasting less than 48 hours. There is no evidence that prophylaxis administered for longer than 48 hours is more effective than a 48-hour regimen.

Optimal Practice: Antibiotic prophylaxis is not continued for more than 48 hours postoperatively. Class IIa. Level B.

Definitions:

Levels of Evidence

Level A: Data derived from multiple randomized clinical trials

Level B: Data derived from a single randomized trial or from nonrandomized trials

Level C: Consensus expert opinion

Classification of Recommendations

Class I: Conditions for which there is evidence and/or general agreement that a given procedure is useful and effective

Class II: Conditions for which there is conflicting evidence and/or a divergence of opinion about the usefulness/efficacy of a procedure

IIa: Weight of evidence favors usefulness/efficacy.

IIb: Usefulness/efficacy is less well established by evidence.

Class III: Conditions for which there is evidence and/or general agreement that the procedure is not useful/effective

CLINICAL ALGORITHM(S)

None provided

EVIDENCE SUPPORTING THE RECOMMENDATIONS

TYPE OF EVIDENCE SUPPORTING THE RECOMMENDATIONS

The type of evidence is identified and graded for some recommendations (see "Major Recommendations" field).

IDENTIFYING INFORMATION AND AVAILABILITY

BIBLIOGRAPHIC SOURCE(S)

  • Society of Thoracic Surgeons Workforce on Evidence Based Surgery. Antibiotic prophylaxis in cardiac surgery. Part 1, duration of prophylaxis. Chicago (IL): Society of Thoracic Surgeons; 2005. 20 p. [56 references]

ADAPTATION

Not applicable: The guideline was not adapted from another source.

DATE RELEASED

2005

GUIDELINE DEVELOPER(S)

Society of Thoracic Surgeons - Medical Specialty Society

SOURCE(S) OF FUNDING

Society of Thoracic Surgeons

GUIDELINE COMMITTEE

Workforce on Evidence Based Surgery

COMPOSITION OF GROUP THAT AUTHORED THE GUIDELINE

Not stated

FINANCIAL DISCLOSURES/CONFLICTS OF INTEREST

Not stated

GUIDELINE STATUS

This is the current release of the guideline.

GUIDELINE AVAILABILITY

Electronic copies: Available in Portable Document Format (PDF) from the Society of Thoracic Surgeons Web site.

Print copies: Available from The Society of Thoracic Surgeons, 633 N. Saint Clair St., Suite 2320, Chicago, IL, USA 60611-3658

AVAILABILITY OF COMPANION DOCUMENTS

None available

PATIENT RESOURCES

None available

NGC STATUS

This NGC summary was completed by ECRI on July 28, 2005.

COPYRIGHT STATEMENT

© 2005 The Society of Thoracic Surgeons
The Society of Thoracic Surgeons Practice Guidelines may be printed or downloaded for individual and personal use only. Guidelines may not be reproduced in any print or electronic publication or offered for sale or distribution in any format without the express written permission of the Society of thoracic Surgeons.

DISCLAIMER

NGC DISCLAIMER

The National Guideline Clearinghouse™ (NGC) does not develop, produce, approve, or endorse the guidelines represented on this site.

All guidelines summarized by NGC and hosted on our site are produced under the auspices of medical specialty societies, relevant professional associations, public or private organizations, other government agencies, health care organizations or plans, and similar entities.

Guidelines represented on the NGC Web site are submitted by guideline developers, and are screened solely to determine that they meet the NGC Inclusion Criteria which may be found at http://www.guideline.gov/about/inclusion.aspx .

NGC, AHRQ, and its contractor ECRI Institute make no warranties concerning the content or clinical efficacy or effectiveness of the clinical practice guidelines and related materials represented on this site. Moreover, the views and opinions of developers or authors of guidelines represented on this site do not necessarily state or reflect those of NGC, AHRQ, or its contractor ECRI Institute, and inclusion or hosting of guidelines in NGC may not be used for advertising or commercial endorsement purposes.

Readers with questions regarding guideline content are directed to contact the guideline developer.


 

 

   
DHHS Logo